PUMA-Mediated Apoptosis Drives Chemical Hepatocarcinogenesis in Mice

被引:73
作者
Qiu, Wei
Wang, Xinwei
Leibowitz, Brian
Yang, Wancai [3 ]
Zhang, Lin [2 ]
Yu, Jian [1 ]
机构
[1] Univ Pittsburgh, Hillman Canc Ctr Res Pavil, Sch Med, Univ Pittsburgh Canc Inst,Dept Pathol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA
[3] Univ Illinois, Dept Pathol, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; BH3-ONLY PROTEINS; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; LIVER INFLAMMATION; CANCER CELLS; DNA-DAMAGE; STEM-CELLS; TUMORIGENESIS; BCL-2;
D O I
10.1002/hep.24516
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocyte death and proliferation contribute to hepatocellular carcinoma development after carcinogen exposure or chronic liver inflammation. However, the role and the molecular targets of hepatocyte death in relation to compensatory proliferation have not been fully characterized. In this study, we investigated the role of p53 up-regulated modulator of apoptosis (PUMA), a BH3-only protein important for both p53-dependent and -independent apoptosis, in a diethylnitrosamine (DEN)-induced liver carcinogenesis model. PUMA deficiency significantly decreased the multiplicity and size of liver tumors. DEN treatment induced p53-independent PUMA expression, PUMA-dependent hepatocyte death, and compensatory proliferation. Furthermore, inhibition or deletion of c-jun N-terminal kinase 1 (JNK1) abrogated PUMA induction, hepatocyte death, and compensatory proliferation. Conclusion: These results provide direct evidence that JNK1/PUMA-dependent apoptosis promotes chemical hepatocarcinogenesis through compensatory proliferation, and suggest apoptotic inducers as potential therapeutic targets in liver injury and cancer. (HEPATOLOGY 2011;54:1249-1258)
引用
收藏
页码:1249 / 1258
页数:10
相关论文
共 57 条
[1]   The Bcl-2 apoptotic switch in cancer development and therapy [J].
Adams, J. M. ;
Cory, S. .
ONCOGENE, 2007, 26 (09) :1324-1337
[2]   Expressional and mutational analysis of pro-apoptotic bcl-2 member PUMA in hepatocellular carcinomas [J].
Ahn, Chang H. ;
Jeong, Eun G. ;
Kim, Sung S. ;
Lee, Jong W. ;
Lee, Sung H. ;
Kim, Sung H. ;
Kim, Min S. ;
Yoo, Nam J. ;
Lee, Sug Hyung .
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (05) :1395-1399
[3]   Deletion of bid impedes cell proliferation and hepatic carcinogenesis [J].
Bai, L ;
Ni, HM ;
Chen, XY ;
DiFrancesca, D ;
Yin, XM .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (05) :1523-1532
[4]   Focus on hepatocellular carcinoma [J].
Bruix, J ;
Boix, L ;
Sala, M ;
Llovet, JM .
CANCER CELL, 2004, 5 (03) :215-219
[5]   MUTATIONAL ACTIVATION OF THE C-HA-RAS GENE IN LIVER-TUMORS OF DIFFERENT RODENT STRAINS - CORRELATION WITH SUSCEPTIBILITY TO HEPATOCARCINOGENESIS [J].
BUCHMANN, A ;
BAUERHOFMANN, R ;
MAHR, J ;
DRINKWATER, NR ;
LUZ, A ;
SCHWARZ, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (03) :911-915
[6]   Apoptosis in stages of mouse hepatocarcinogenesis: Failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility [J].
Bursch, W ;
Chabicovsky, M ;
Wastl, U ;
Grasl-Kraupp, B ;
Bukowska, K ;
Taper, H ;
Schulte-Hermann, R .
TOXICOLOGICAL SCIENCES, 2005, 85 (01) :515-529
[7]   JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis [J].
Cazanave, Sophie C. ;
Mott, Justin L. ;
Elmi, Nafisa A. ;
Bronk, Steven F. ;
Werneburg, Nathan W. ;
Akazawa, Yuko ;
Kahraman, Alisan ;
Garrison, Sean P. ;
Zambetti, Gerard P. ;
Charlton, Michael R. ;
Gores, Gregory J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (39) :26591-26602
[8]   tRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality [J].
Corazza, Nadia ;
Jakob, Sabine ;
Schaer, Corinne ;
Frese, Steffen ;
Keogh, Adrian ;
Stroka, Deborah ;
Kassahn, Daniela ;
Torgler, Ralph ;
Mueller, Christoph ;
Schneider, Pascal ;
Brunner, Thomas .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (09) :2493-2499
[9]  
de la Coste A, 1999, CANCER RES, V59, P5017
[10]   Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53 [J].
Eferl, R ;
Ricci, R ;
Kenner, L ;
Zenz, R ;
David, JP ;
Rath, M ;
Wagner, EF .
CELL, 2003, 112 (02) :181-192